NSCLC HER3 AE Management
Optimizing HER3-Targeted Therapy for NSCLC: Strategies for Early Detection and Management of Adverse Events

Released: December 05, 2024

Expiration: December 04, 2025

Karen Reckamp
Karen Reckamp, MD, MS

Activity

Progress
1
Course Completed